教室紹介、スタッフ紹介、研究、業績等、順天堂大学大学院腎臓内科学に関する様々な情報をご案内します。


業績

 
腎臓内科への入局・大学院進学をお考えの方へ
|2018|201720162015201420132012
【英文論文 2018】
  1. Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.: IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int. 2018; 93: 700-705.
  2. Ohsawa I, Honda D, Hisada A, Inoshita H, Onda-Tsueshita K, Mano S, Sato N, Nakamura Y, Shimizu T, Gotoh H, Goto Y, Suzuki Y, Tomino Y.: Clinical Features of Hereditary and Mast Cell-mediated Angioedema Focusing on the Differential Diagnosis in Japanese Patients. Intern Med. 2018; 57:319-324.
  3. Hamada C, Nakamoto H, Suzuki Y.: Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis. J Artif Organs. 2018; 21:102-109.
  4. Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H.: Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. PLOS ONE. 2018; 13: e0190967.
  5. Taguchi K, Yamagishi S, Yokoro M, Ito S, Kodama G, Kaida Y, Nakayama Y, Ando R, Yamada-Obara N, Asanuma K, Matsui T, Higashimoto Y, Brooks CR, Ueda S, Okuda S, Fukami K.: RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice. Sci Rep. 2018; 8: 2686.
  6. Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T.: Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS. Clin Exp Nephrol. 2018; 22(2):377-387.
  7. Asao R, Seki T, Takagi M, Yamada H, Kodama F, Hosoe-Nagai Y, Tanaka E, Trejo JAO, Yamamoto-Nonaka K, Sasaki Y, Hidaka T, Ueno T, Yanagita M, Suzuki Y, Tomino Y, Asanuma K. Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis. Sci Rep. 2018; 8(1):5061.
  8. Gohda T, Nishizaki Y, Murakoshi M, Nojiri S, Yanagisawa N, Shibata T, Yamashita M, Tanaka K, Yamashita Y, Suzuki Y, Kamei N. Clinical predictive biomarkers for normoalbuminuric diabetic kidney disease. Diabetes Res Clin Pract. 2018; 3(141):62-68.
  9. Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol. 018 ; 22 (6) : 1266 - 1280.
  10. Honda D, Ohsawa I, Shimizu Y, Maiguma M, Hidaka T, Suzuki H, Io H, Mano S, Takahara H, Rinno H, Tomino Y, Suzuki Y. Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan. Intern Med. 2018 ; 57 (21) : 3193 - 3197.
  11. Kaifu K, Ueda S, Nakamura N, Matsui T, Yamada-Obara N, Ando R, Kaida Y, Nakata M, Matsukuma-Toyonaga M, Higashimoto Y, Fukami K, Suzuki Y, Okuda S, Yamagishi SI. Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4. Microvasc Res. 120 : 90-93.
  12. Kubo A, Shirato I, Hidaka T, Takagi M, Sasaki Y, Asanuma K, Ishidoh K, Suzuki Y. Expression of Cathepsin L and Its Intrinsic Inhibitors in Glomeruli of Rats With Puromycin Aminonucleoside Nephrosis. J Histochem Cytochem. 2018 ; 66(12) : 863 - 877.
  13. Ikeda M, Terawaki H, Kanda E, Furuya M, Tanno Y, Nakao M, Maruyama Y, Maeda M, Higuchi C, Sakurada T, Kaneko T, Io H, Hashimoto K, Ueda A, Hirano K, Washida N, Yoshida H, Yoshikawa K, Taniyama Y, Harada K, Matsuo N, Okido I, Yokoo T. Interventional nephrology: current status and clinical impact in Japan. Clin Exp Nephrol. 22(2):437-447.
  14. Suzuki H. Can Biomarkets Help in the Diagnosis and Management of IgAN?. Kidney Diseases. 4:145-194.
  15. Suzuki Y. B Cells in IgAN and the Rationale for B Cell Directed Therapies in IgAN. Kidney Diseases. 4:145-194.
  16. Io H, Suzuki Y. Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients. Contrib Nephrol. 196:13-21.
  17. Honda D, Ohsawa I, Shimizu Y, Maiguma M, Hidaka T, Suzuki H, Io H, Mano S, Takahara H, Rinno H, Tomino Y, Suzuki Y. Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan. Intern Med. 1;57(21):3193-3197.
  18. Thaha M, Empitu MA, Kadariswantiningsih IN, Nugroho CW, Hasanatulidhhiyah N, Rasyid H, EI Hakim Z, Suryansyah MM, Alda RR, Alsagaff MY, Amin M, Santoso D, Suzuki Y. Anthropometry-based Body Fat Percentage Predicts High hs-CRP in Chronic Kidney Disease Patients. Indones Biomed J. 10(2):184-191.
  19. Sato D, Gohda T, Kihara M, Kanaguchi Y, Kobayashi T, Mano S, Sasaki Y, Nohara N, Murakoshi M, Nakata J, Suzuki H, Ueda S, Horikoshi S, Suzuki Y. Effect of Zinc Acetate Dihydrate (NobelzinR) Tretement on Anemia and Taste Disorders in Patients with Chronic Kidney Disease with Hypozincemia. Acta Medica Okayama. 72;(5): 535-538.
  20. Kamei N, Yamashita M, Nishizaki Y, Yanagisawa N, Nojiri S, Tanaka K, Yamashita Y, Shibata T, Murakoshi M, Suzuki Y, Gohda T. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes. Sci Rep. 8; (1) : 15302.
  21. Inoue M, Yamamotoya T, Nakatsu Y, Ueda K, Inoue Y, Matsunaga Y, Sakoda H, Fujishiro M, Ono H, Morii K, Sasaki K, Masaki T, Suzuki Y, Asano T, Kushiyama K. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model. Int. J. Mol. Sci. 19(12). pii: E3967.
  22. Suzuki H, Suzuki Y. Murine Models of Human IgA Nephropathy. Semin Nephrol. ; 38 (5) : 513 - 520.
  23. Takahashi K, Ueda K, Kobayashi T, Nishiyama A, Fujisawa T, Sugaya T, Shiota S, Takahashi K, Gohda T, Horikoshi S, Suzuki Y. Chronic intermittent hypoxia-madiated renal sympathetic nerve activation in hypertension and cardiovascular disease. Sci Rep. 8(1):17926.
  24. Yamasaki K, Suzuki H, Yasutake J, Yamasaki Y, Suzuki Y. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1. Monoclon Antib Immunodiagn Immunother. 37(6):252-256.
 
Copyright © 2005 JUNTENDO All Rights Reserved.